| Literature DB >> 35565456 |
Kenji Kawada1, Toshiaki Wada1,2, Takehito Yamamoto1,3, Yoshiro Itatani1, Koya Hida1, Kazutaka Obama1.
Abstract
In order to prevent anastomotic leakage (AL) following rectal surgery, various solutions-such as intraoperative indocyanine green (ICG) angiography and transanal drainage tubes (TDT)-have been proposed. This study investigated the relationship between intestinal perfusion and fecal volume through TDT in laparoscopic low anterior resection (LAR). A total of 59 rectal cancer patients who underwent laparoscopic LAR with both intraoperative ICG angiography and postoperative TDT placement were retrospectively analyzed. The relationship between intestinal perfusion and fecal volume through TDT was examined. Based on the ICG fluorescence, the transection site was shifted more proximally in 20 cases (33.9%). Symptomatic AL occurred in seven patients (11.8%). The AL rate of the patients whose daily fecal volume exceeded 100 mL/day in 2 or more days was significantly higher than that of those whose daily fecal volume exceeded it in 0 or 1 day (44.4% vs. 6.0%; p < 0.01). Univariate and multivariate analyses showed that the need for a proximal shift of the transection site was significantly associated with a high fecal volume. The quantitative analysis of ICG fluorescence indicated that Fmax (the fluorescence difference between the baseline and maximum) was significantly associated with fecal volume through TDT.Entities:
Keywords: ICG angiography; anastomotic leakage; rectal cancer; transanal drainage tube
Year: 2022 PMID: 35565456 PMCID: PMC9101401 DOI: 10.3390/cancers14092328
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.575
Figure 1Time curve of the ICG fluorescence intensity. Fmax, Tmax, T1/2, and Slope were calculated.
Univariate and multivariate analyses of the risk factors associated with a high fecal volume.
| Variables | Patients with High TDT Discharge | Univariate | Multivariate |
|---|---|---|---|
| Age, years | 0.97 | ||
| <70 | 6/39 15.4 | ||
| ≥70 | 3/20 15.0 | ||
| Sex | 0.020 | 0.99 | |
| Male | 9/39 23.1 | ||
| Female | 0/20 0.0 | ||
| BMI, kg/m2 | 0.22 | ||
| <25 | 6/48 12.5 | ||
| ≥25 | 3/11 27.3 | ||
| Albumin, g/dL | 0.98 | ||
| <4.0 | 4/26 15.4 | ||
| ≥4.0 | 5/33 15.2 | ||
| Hemoglobin, g/dL | 0.06 | ||
| <11 | 3/8 37.5 | ||
| ≥11 | 6/51 11.8 | ||
| Location | 0.99 | ||
| Upper | 7/46 15.2 | ||
| Lower | 2/13 15.4 | ||
| Operation time, min | 0.039 | 0.056 | |
| <300 | 1/25 4.0 | ||
| ≥300 | 8/34 23.5 | ||
| Blood loss, mL | 0.53 | ||
| <50 | 8/48 16.7 | ||
| ≥50 | 1/11 9.1 | ||
| Tumor size, cm | 0.80 | ||
| <5.0 | 5/35 14.3 | ||
| ≥5.0 | 4/24 16.7 | ||
| T category | 0.42 | ||
| Tis, T1, T2 | 2/20 10.0 | ||
| T3, T4 | 7/39 17.9 | ||
| N category | 0.11 | ||
| N0 | 3/34 8.8 | ||
| N1, N2 | 6/25 24.0 | ||
| Ligation of IMA | 0.16 | ||
| high ligation | 8/57 14.0 | ||
| low ligation | 1/2 50.0 | ||
| LLND | 0.45 | ||
| Yes | 0/3 0.0 | ||
| No | 9/56 16.1 | ||
| Preoperative chemotherapy | 0.92 | ||
| No | 1/6 16.7 | ||
| Yes | 8/53 15.1 | ||
| Anastomosis level from AV, mm | 0.30 | ||
| <40 | 3/28 10.7 | ||
| ≥40 | 6/31 19.4 | ||
| Diabetes Mellitus | 0.19 | ||
| No | 7/53 13.2 | ||
| Yes | 2/6 33.3 | ||
| Anticoagulation Therapy | 0.30 | ||
| No | 7/52 13.5 | ||
| Yes | 2/7 28.6 | ||
| Steroid therapy | 0.045 | 0.09 | |
| No | 7/55 12.7 | ||
| Yes | 2/4 50.0 | ||
| Smoking, Brinkman index | 0.63 | ||
| <400 | 5/37 13.5 | ||
| ≥400 | 4/22 18.2 | ||
| Proximal change of resection site | 0.003 | 0.004 43.6 | |
| No | 2/39 5.1 | ||
| Yes | 7/20 35.0 |
Abbreviations: LLND, lateral lymph node dissection; OR, odds ratio.
Figure 2Analysis of the ICG fluorescence-related parameters according to the TDT discharge volume. Fmax (A), Tmax (B), T1/2 (C) and Slope (D). Medians, bars. Mann-Whitney U test.
Clinical characteristics of the AL cases.
| Case | AL | Sex | Operation | Diabetes | Anticoagulation | Steroid | Fecal | Change of Resection Site | Fmax at Transection Site | Slope at Transection Site |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | C | male | ≥300 | No | No | No | high | Yes | 27.2 | 0.3 |
| 2 | C | male | ≥300 | Yes | No | No | high | Yes | 30.6 | 0.5 |
| 3 | C | male | ≥300 | Yes | No | No | low | No | 49.4 | 2.0 |
| 4 | C | male | ≥300 | No | No | No | low | Yes | 31.8 | 1.3 |
| 5 | B | male | ≥300 | No | Yes | No | high | Yes | 51.7 | 0.8 |
| 6 | C | male | <300 | No | No | No | high | Yes | 49.1 | 1.2 |
| 7 | C | female | <300 | No | No | No | low | Yes | 20.2 | 0.5 |